TCMD — Tactile Systems Technology Inc

Tactile Systems Technology Inc (TCMD) is a medical devices company listed on NASDAQ. It is led by Sheri Louise Dodd, based in 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416, with about 1,086 employees. Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Latest reported TCMD revenue for 2025-09-30 was $85.8M. Net income was $8.5M. Revenue was up 8.7% from 2025-06-30 to 2025-09-30. TCMD currently screens at market cap $590.1M and trailing P/E 30.1.

Use this TCMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TCMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TCMD SEC filings page. Lician reads the product cache first so this HTML stays unique to Tactile Systems Technology Inc even when a live quote feed is slow.